Hi, what are you looking for?
Jewish Business News
Search results for "Teva Pharmaceutical Industries"
Business
Copaxone’s patent remains in force at least until the Federal Circuit Appeals Court reconsiders the case. The rivals of Teva Pharmaceutical Industries Ltd. (NYSE:...
Business
Berenberg analysts see insurance companies pressuring MS patients to switch to generic versions of Copaxone. Last year, Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE:...
Business
Bloomberg reports that increased competition with cheaper generics may push Teva to make a major acquisition soon. Perrigo Company (NYSE:PRGO; TASE:PRGO) may be a...
Business
– Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has announced : the Food and Drug Administration (FDA) approval and the launch of the...
Business
– The QNASL nasal spray, approved in 2012 for adults, treats nasal symptoms of allergic rhinitis, including hay fever, in children. Teva Pharmaceutical Industries...
Business
– Relations between Teva and Biotec have deteriorated into a legal dispute and an entanglement with the Russian authorities. – After years of...
Business
– Teva has lost its 180 days exclusivity for the generic version of Pfizer’s arthritis and chronic pain treatment. – The US Supreme...
Business
– “We are upgrading our recommendation for Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) from “Market perform” to “Market outperform” with a target...
Business
– Generic competition for Copaxone and foreign currency volatility will hit Teva’s sales. – When Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA)...
Leadership & A-List
– Teva Pharmaceutical Industries Ltd. ((NYSE: TEVA; TASE: TEVA) today announced that the Board of Directors has elected Professor Yitzhak Peterburg as Chairman, effective January 1,...